These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8179475)

  • 1. The influence of substituents in 3-position on the activity of chroman-type potassium channel activators.
    Bergmann R; Gericke R
    Arch Pharm (Weinheim); 1994 Mar; 327(3):169-73. PubMed ID: 8179475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators.
    Bergmann R; Gericke R
    J Med Chem; 1990 Feb; 33(2):492-504. PubMed ID: 2299619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiophene systems. 14. Synthesis and antihypertensive activity of novel 7-(cyclic amido)-6-hydroxythieno[3,2-b]pyrans and related compounds as new potassium channel activators.
    Sanfilippo PJ; McNally JJ; Press JB; Fitzpatrick LJ; Urbanski MJ; Katz LB; Giardino E; Falotico R; Salata J; Moore JB
    J Med Chem; 1992 Nov; 35(23):4425-33. PubMed ID: 1447742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel potassium channel activators: synthesis and structure-activity relationship studies of 3,4-dihydro-2H-1,4-benzoxazine derivatives.
    Matsumoto Y; Tsuzuki R; Matsuhisa A; Takayama K; Yoden T; Uchida W; Asano M; Fujita S; Yanagisawa I; Fujikura T
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):103-14. PubMed ID: 8582029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of novel and selective I(Ks)-channel blockers.
    Gerlach U; Brendel J; Lang HJ; Paulus EF; Weidmann K; Brüggemann A; Busch AE; Suessbrich H; Bleich M; Greger R
    J Med Chem; 2001 Nov; 44(23):3831-7. PubMed ID: 11689069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,2-Dialkylnaphthalen-1-ones as new potassium channel activators.
    Almansa C; Gómez LA; Cavalcanti FL; Rodríguez R; Carceller E; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1993 Jul; 36(15):2121-33. PubMed ID: 8340916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of novel 1,3-benzoxazine derivatives as K+ channel openers.
    Yamamoto S; Hashiguchi S; Miki S; Igata Y; Watanabe T; Shiraishi M
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):734-45. PubMed ID: 8681405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K+ channel activators, acute glucose tolerance and glibenclamide-induced hypoglycaemia in the hypertensive rat.
    Clapham JC; Trail BK; Hamilton TC
    Eur J Pharmacol; 1994 May; 257(1-2):79-85. PubMed ID: 8082711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF; de Azevedo Carvalho AC; Pimentel EB; Mill JG; Nascimento JH
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):225-234. PubMed ID: 27915452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
    Horino H; Mimura T; Kagechika K; Ohta M; Kubo H; Kitagawa M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):602-9. PubMed ID: 9579035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cerebrovascular response to a potassium channel opener in hypertensive rats.
    Takaba H; Nagao T; Ibayashi S; Kitazono T; Fujii K; Fujishima M
    Hypertension; 1996 Jul; 28(1):143-6. PubMed ID: 8675255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramipril treatment alters Ca(2+) and K(+) channels in small mesenteric arteries from Wistar-Kyoto and spontaneously hypertensive rats.
    Cox RH; Lozinskaya I; Matsuda K; Dietz NJ
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):879-90. PubMed ID: 12372675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potassium-channel openers: preparation and pharmacological evaluation of racemic and optically active N-(6-amino-3-pyridyl)-N'-bicycloalkyl-N"-cyanoguanidine derivatives.
    Eda M; Takemoto T; Ono S; Okada T; Kosaka K; Gohda M; Matzno S; Nakamura N; Fukaya C
    J Med Chem; 1994 Jun; 37(13):1983-90. PubMed ID: 8027980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension.
    Wang H; Long CL; Zhang YL
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1326-33. PubMed ID: 15525792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of novel phenylcyanoguanidine derivatives as potassium channel openers.
    Yoshiizumi K; Ikeda S; Goto K; Morita T; Nishimura N; Sukamoto T; Yoshino K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2042-50. PubMed ID: 8945769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogs.
    Kusumoto K; Awane Y; Kitayoshi T; Fujiwara S; Hashiguchi S; Terashita Z; Shiraishi M; Watanabe T
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):929-36. PubMed ID: 7898076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Heterocyclyloxy-2H-1-benzopyran potassium channel activators.
    Bergmann R; Eiermann V; Gericke R
    J Med Chem; 1990 Oct; 33(10):2759-67. PubMed ID: 2213828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular pharmacological characterization of novel 2,3-dimethyl-2-butylamine derivatives in rats.
    Chen YP; Qiu CR; Wang H
    Life Sci; 2004 Sep; 75(17):2131-42. PubMed ID: 15312756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel thieno[2,3-b]- and [3,4-b]pyrans as potassium channel openers. Thiophene systems--XVII.
    Press JB; McNally JJ; Sanfilippo PJ; Addo MF; Loughney D; Giardino E; Katz LB; Falotico R; Haertlein BJ
    Bioorg Med Chem; 1993 Dec; 1(6):423-35. PubMed ID: 8087564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.